By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Survey Evaluating The Prevalence Of Pseudobulbar Affect (PBA) Symptoms In Retired Professional Football Players At The 12th Annual North American Brain Injury Society Conference 5/5/2015 10:34:52 AM
AVANIR Pharmaceuticals (AVNR) Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise At The American Academy of Neurology 2015 Annual Meeting 4/15/2015 10:34:06 AM
AVANIR Pharmaceuticals (AVNR) Release: Through Laughter And Tears Comes First-Ever Documentary About Life With Pseudobulbar Affect (PBA) 12/9/2014 9:30:53 AM
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014 7:28:00 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014 11:48:10 AM
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014 6:21:23 AM
AVANIR Pharmaceuticals (AVNR) Receives Complete Response Letter (CRL) From FDA On AVP-825 NDA 12/1/2014 9:15:10 AM
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014 2:04:45 PM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In December 11/20/2014 12:29:41 PM
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline 11/7/2014 8:31:20 AM